InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Handley Michael K, Chairman & CEO. Officer active across 1 company, notably Cytocom, Inc.. Aggregated, 2 reports have been logged. History available since 27 July 2021. The latest transaction was filed on 27 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
296,609 shares0Common Stock, par value $0.005 per shareSEC:0001437749-21-018563:0
296,609 shares0Common Stock, par value $0.005 per shareSEC:0001437749-21-018563
2 of 2 declarations
About Handley Michael K
Michael K. Handley is the President and CEO of Cytocom, Inc. He leads the company with a strategic vision focused on innovation and growth. Handley brings significant expertise in business management and product development, thus contributing to Cytocom's mission to provide advanced therapeutic solutions. His leadership is essential for navigating the dynamic biotechnology market.
